M MagellanLONGEVITY

AMPK / Metabolic

D-Glucosamine

D-Glucosamine, an amino-sugar used for joint health, acts as a calorie-restriction mimetic — activating AMPK via the hexosamine pathway — and regular use is linked in large human cohorts to lower all-cause and cardiovascular mortality.

Energy-restriction mimetic; activates AMPK via the hexosamine pathway. Linked to lower mortality.

Research-backed interactions

lowers All-cause mortality

Regular glucosamine use was associated with significantly lower all-cause, cardiovascular, cancer, respiratory and digestive mortality (all-cause HR 0.73).

Annals of the Rheumatic Diseases, 2020 · PubMed 32253185

increases Lifespan (Mendelian randomization)

Higher genetically predicted glucosamine was associated with greater odds of extended parental lifespan, consistent with a causal effect on longevity.

Mendelian Randomization study, 2022 · PubMed 35623867

lowers Cardiovascular mortality

Glucosamine/chondroitin use was associated with reduced all-cause mortality in a nationally representative U.S. cohort.

Frontiers in Pharmacology (NHANES), 2020 · PubMed 33219063

Products

Curated supplements. Links are affiliate (Amazon Associates, tag magellanlong-20) — we may earn a commission at no cost to you.

Frequently asked

How does D-Glucosamine relate to longevity?

D-Glucosamine, an amino-sugar used for joint health, acts as a calorie-restriction mimetic — activating AMPK via the hexosamine pathway — and regular use is linked in large human cohorts to lower all-cause and cardiovascular mortality.

How is D-Glucosamine related to All-cause mortality?

Regular glucosamine use was associated with significantly lower all-cause, cardiovascular, cancer, respiratory and digestive mortality (all-cause HR 0.73).

How is D-Glucosamine related to Lifespan (Mendelian randomization)?

Higher genetically predicted glucosamine was associated with greater odds of extended parental lifespan, consistent with a causal effect on longevity.

How is D-Glucosamine related to Cardiovascular mortality?

Glucosamine/chondroitin use was associated with reduced all-cause mortality in a nationally representative U.S. cohort.